Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Goodwill (2016 - 2017)

Altimmune (ALT) has disclosed Goodwill for 8 consecutive years, with $9.3 million as the latest value for Q3 2017.

  • On a quarterly basis, Goodwill rose 297.49% to $9.3 million in Q3 2017 year-over-year; TTM through Sep 2017 was $9.3 million, a 297.49% increase, with the full-year FY2016 number at $18.8 million, down 16.61% from a year prior.
  • Goodwill was $9.3 million for Q3 2017 at Altimmune, down from $35.4 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $35.4 million in Q2 2017 to a low of $2.3 million in Q1 2013.
  • A 5-year average of $6.6 million and a median of $2.3 million in 2013 define the central range for Goodwill.
  • Peak YoY movement for Goodwill: fell 16.61% in 2016, then soared 1407.33% in 2017.
  • Altimmune's Goodwill stood at $2.3 million in 2013, then changed by 0.0% to $2.3 million in 2014, then skyrocketed by 857.85% to $22.5 million in 2015, then decreased by 16.61% to $18.8 million in 2016, then plummeted by 50.24% to $9.3 million in 2017.
  • Per Business Quant, the three most recent readings for ALT's Goodwill are $9.3 million (Q3 2017), $35.4 million (Q2 2017), and $2.3 million (Q1 2017).